STRATA Skin Sciences, Inc.
NASDAQ:SSKN
2.94 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 33.358 | 36.161 | 29.977 | 23.09 | 31.586 | 29.855 | 31.449 | 31.757 | 18.495 | 0.915 | 0.536 | 0.278 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 |
| Cost of Revenue
| 14.897 | 14.393 | 10.127 | 8.956 | 11.316 | 12.735 | 13.498 | 12.636 | 13.719 | 4.935 | 4.341 | 2.042 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.248 |
| Gross Profit
| 18.461 | 21.768 | 19.85 | 14.134 | 20.27 | 17.12 | 17.951 | 19.121 | 4.776 | -4.02 | -3.805 | -1.764 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.038 |
| Gross Profit Ratio
| 0.553 | 0.602 | 0.662 | 0.612 | 0.642 | 0.573 | 0.571 | 0.602 | 0.258 | -4.393 | -7.099 | -6.334 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.181 |
| Reseach & Development Expenses
| 1.317 | 1.029 | 1.434 | 1.274 | 1.002 | 1.065 | 1.711 | 1.929 | 2.029 | 1.641 | 3.782 | 6.792 | 9.656 | 11.497 | 10.95 | 12.508 | 7.678 | 7.575 | 3.822 | 1.892 | 0.828 | 0.404 | 0.144 | 0.726 |
| General & Administrative Expenses
| 10.508 | 10.087 | 9.712 | 7.898 | 10.275 | 8.786 | 7.401 | 7.637 | 10.028 | 10.961 | 15.536 | 14.169 | 10.806 | 8.738 | 7.631 | 5.766 | 5.4 | 4.526 | 2.636 | 1.234 | 1.034 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 12.956 | 15.301 | 13.106 | 9.038 | 12.003 | 10.624 | 11.249 | 13.152 | 9.194 | 3.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 23.464 | 25.388 | 22.818 | 16.936 | 22.278 | 19.41 | 18.65 | 20.789 | 19.222 | 10.961 | 15.536 | 14.169 | 10.806 | 8.738 | 7.631 | 5.766 | 5.4 | 4.526 | 2.636 | 1.234 | 1.034 | 0.511 | 2.563 | 1.061 |
| Other Expenses
| 2.284 | 0 | 0 | 0 | 0 | 0.2 | 0.017 | 0.021 | 0.033 | 0.15 | 0.021 | 0.02 | 0 | 0.281 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.563 | 1.061 |
| Operating Expenses
| 24.781 | 26.417 | 24.252 | 18.21 | 23.28 | 20.475 | 20.361 | 22.718 | 21.251 | 12.602 | 19.318 | 20.961 | 20.462 | 20.235 | 18.581 | 18.274 | 13.078 | 12.101 | 6.458 | 3.126 | 1.862 | 0.915 | 2.707 | 1.787 |
| Operating Income
| -6.32 | -4.56 | -4.402 | -4.076 | -2.596 | -3.355 | -2.41 | -3.597 | -16.475 | -16.622 | -24.134 | -22.725 | -20.462 | -20.235 | -18.581 | -18.274 | -13.078 | -12.101 | -6.458 | -3.126 | -1.862 | -0.915 | -2.707 | -1.825 |
| Operating Income Ratio
| -0.189 | -0.126 | -0.147 | -0.177 | -0.082 | -0.112 | -0.077 | -0.113 | -0.891 | -18.166 | -45.026 | -81.608 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.69 |
| Total Other Income Expenses Net
| -4.602 | -0.926 | 1.73 | -0.061 | -1.343 | -0.942 | -16.292 | 0.517 | -8.353 | 2.477 | -1.814 | 0.052 | 0.023 | 0.281 | 0.083 | 0.202 | 0.059 | 1,509.056 | -2,544.502 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -10.922 | -5.486 | -2.672 | -4.137 | -3.939 | -4.297 | -18.702 | -3.08 | -24.828 | -14.145 | -25.948 | -22.673 | -20.385 | -19.923 | -18.453 | -17,605.031 | -11,937.444 | -10,591.477 | -9,002.278 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -0.327 | -0.152 | -0.089 | -0.179 | -0.125 | -0.144 | -0.595 | -0.097 | -1.342 | -15.459 | -48.41 | -81.421 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.092 | 0.063 | 0.034 | 0.275 | -0.149 | -0.264 | 0.129 | 0.255 | 0.119 | 6.744 | -1.25 | 0.053 | -0.078 | -0.312 | -0.129 | -0.669 | -1.141 | 1,507.547 | -2,544.233 | 0.493 | 0.058 | 1.141 | 2.868 | 2.28 |
| Net Income
| -10.83 | -5.549 | -2.706 | -4.412 | -3.79 | -4.033 | -21.514 | -3.335 | -27.909 | -16.032 | -25.948 | -22.673 | -20.385 | -19.923 | -18.453 | -17.605 | -11.937 | -10.591 | -6.726 | -3.619 | -1.95 | -1.141 | -2.868 | -2.28 |
| Net Income Ratio
| -0.325 | -0.153 | -0.09 | -0.191 | -0.12 | -0.135 | -0.677 | -0.109 | -1.509 | -17.521 | -48.41 | -81.558 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.857 |
| EPS
| -3.1 | -1.6 | -0.79 | -1.31 | -1.18 | -1.48 | -32.6 | -15.74 | -163.46 | -151.36 | -302.46 | -36.85 | -40.1 | -41.43 | -47.82 | -54.06 | -41.97 | -46.89 | -95.85 | -102.43 | -60.38 | -37.17 | -93.44 | -74.54 |
| EPS Diluted
| -3.1 | -1.6 | -0.79 | -1.31 | -1.18 | -1.48 | -32.6 | -37.7 | -163.5 | -151.36 | -302.46 | -36.85 | -40.1 | -41.43 | -47.82 | -54.06 | -41.97 | -46.89 | -95.85 | -102.43 | -60.38 | -37.17 | -93.44 | -74.54 |
| EBITDA
| -0.418 | 1.128 | -0.301 | -0.165 | 2.225 | 1.1 | -12.366 | 3.286 | -20.777 | -9.975 | -22.945 | -21.703 | -19.923 | -19.963 | -18.35 | -18.167 | -12.926 | -11.962 | -6.442 | -3.1 | -1.862 | -0.915 | -2.707 | -1.825 |
| EBITDA Ratio
| -0.013 | 0.031 | -0.01 | -0.007 | 0.07 | 0.037 | -0.393 | 0.103 | -1.123 | -10.902 | -42.808 | -77.939 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.69 |